Skip to main content
. 2022 Apr 29;20:2235–2246. doi: 10.1016/j.csbj.2022.04.034

Table 1.

Demographics and clinicopathologic characteristics of patients in our study.

INCB(N = 38) SYSUCC(N = 59)
Sex (%) Female 12 (31.6) 21 (35.6)
Male 26 (68.4) 38 (64.4)
Age at diagnosis (years) Mean (SD) 55.0 (10.2) 43.6 (14.9)
Pathological diagnosis (%)
Glioblastoma,IDH-wildtype 36 (94.7) 39 (66.1)
Astrocytoma,IDH-mutant 2 (5.3) 14 (23.7)
Oligodendroglioma,IDH-mutant,
1p/19q-codeleted
0 4 (6.8)
Unknown 0 2 (3.4)
Radiotherapy (%) Yes 19 (100.0) 24 (77.4)
No 0 7 (22.6)
Chemotherapy (%) Yes 19 (100.0) 20 (64.5)
No 0 11 (35.5)
Grades (%) 4 38 (100.0) 38 (66.7)
2 0 8 (14.0)
3 0 11 (19.3)
Normal control (%) Yes 38 (100.0) 49 (83.1)
No 0 10 (16.9)